Serotype-specific differences in short- and longer-term mortality following invasive pneumococcal disease

Epidemiology and Infection

Volumn 144, Issue 12, 2016, Pages 2654-2669

  Hughes, G J ^a   Wright, L B ^b   Chapman, K E ^b   Wilson, D ^b   Gorton, R ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Mortality; pneumococcal infections; serotype; survival analysis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; ENGLAND; FEMALE; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; MALE; MORTALITY; NEWBORN; NONHUMAN; PNEUMOCOCCAL INFECTION; PROPORTIONAL HAZARDS MODEL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; SURVIVAL ANALYSIS; VERY ELDERLY; EPIDEMIOLOGY; GENETICS; HEALTH SURVEY; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ENGLAND; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; SEROGROUP; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 84969746060     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268816000856     Document Type: Article

References (18)

1. O'Brien KL, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374: 893-902.
2. Drijkoningen JJC, Rohde GGU. Pneumococcal infection in adults: burden of disease. Clinical Microbiology and Infection 2014; 20 (Suppl. 5): 45-51.
3. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infectious Diseases 2005; 5: 83-93.
4. van Hoek AJ, et al. Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes. PLoS One 2012; 7: e39150.
5. Harboe ZB, et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: A populationbased cohort study. PLoS Medicine 2009; 6: e1000081.
6. Martens P, et al. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infectious Diseases 2004; 4: 21.
7. Weinberger DM, et al. Association of serotype with risk of death due to pneumococcal pneumonia: A meta-analysis. Clinical Infectious Diseases 2010; 51: 692-699.
8. Grabenstein JD, Musey LK. Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults. Vaccine 2014; 32: 2399-2405.
9. Navarro-Torné A, et al. Risk factors for death from invasive pneumococcal disease. Emerging Infectious Diseases 2015; 21: 417-425.
10. Sandvall B, Rueda AM, Musher DM. Long-term survival following pneumococcal pneumonia. Clinical Infectious Diseases 2013; 56: 1145-1146.
11. Roed C, et al. Long-term mortality in patients diagnosed with meningococcal disease: A Danish nationwide cohort study. PLoS One 2010; 5: e9662.
12. Wang HE, et al. Long-term mortality after communityacquired sepsis: A longitudinal population-based cohort study. BMJ Open 2014; 4: e004283.
13. Office for National Statistics. Regional profiles: key statistics-North East, August 2012 (http://www.ons.gov.uk/ ons/dcp171780-228225.pdf). Accessed 6 January 2015.
14. Office for National Statistics. General health in England and Wales, 2011 and comparison with 2001 (http:// www.ons.gov.uk/ons/dcp171776-296871.pdf). Accessed 6 January 2015.
15. McLennan D, et al. The English indices of deprivation 2010 (https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/6320/1870718.pdf). Accessed 6 January 2015.
16. Chapman KE, Wilson D, Gorton R. Serotype dynamics of invasive pneumococcal disease post-PCV7 and pre-PCV13 introduction in North East England. Epidemiology and Infection 2013; 141:344-352.
17. Chapman KE, Wilson D, Gorton R. Invasive pneumococcal disease and socioeconomic deprivation: A population study from the North East of England. Journal of Public Health (Oxford) 2013; 35: 558-569.
18. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons, 2001.